A detailed history of Concurrent Investment Advisors, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Concurrent Investment Advisors, LLC holds 2,072 shares of VRTX stock, worth $1.04 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,072
Previous 1,531 35.34%
Holding current value
$1.04 Million
Previous $718 Million 34.29%
% of portfolio
0.03%
Previous 0.02%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$460.0 - $505.78 $248,860 - $273,626
541 Added 35.34%
2,072 $964 Million
Q2 2024

Jul 30, 2024

BUY
$392.81 - $485.53 $95,845 - $118,469
244 Added 18.96%
1,531 $718 Million
Q1 2024

May 07, 2024

BUY
$407.69 - $446.08 $253,175 - $277,015
621 Added 93.24%
1,287 $538 Million
Q4 2023

Apr 15, 2024

BUY
$343.0 - $410.68 $228,438 - $273,512
666 New
666 $271 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Concurrent Investment Advisors, LLC Portfolio

Follow Concurrent Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concurrent Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Concurrent Investment Advisors, LLC with notifications on news.